This second annual policy report from the Global Health Technologies Coalition—a group of almost 40 nonprofit organizations working to increase awareness of the urgent need for vaccines, diagnostics, drugs, microbicides, and other products that save lives in the developing world—outlines some of the steps that will help curb unnecessary deaths, extend lives, and secure healthier futures. Serving as a guide for policymakers, the report documents promising policy actions taken over the past year in the areas of US investments in global health and international development, regulatory pathways to ensure the safety and efficacy of health tools, and incentives and innovative financing mechanisms to spur global health product development. This report offers recommendations for how US policymakers can continue to have a lead in improving health worldwide.

Publication date: 2011

Region: North America and Europe

Part of series: GHTC's annual policy reports

This special report offers an overview of the proceedings at the 7th International Symposium on Pneumococci and Pneumococcal Diseases held in Tel Aviv, Israel, from March 14 to 18, 2010. The meeting brought together pneumococcal experts from around the world to discuss the latest advancements in the field of pneumococcal disease research and development. This report captures topics covered at the conference ranging from microbiology and epidemiology of the pneumococcus bacterium to existing and novel pneumococcal vaccines and  treatments, as well as updates on global advocacy efforts and serotype dynamics of pneumococcal disease.

Publication date: 2010

Region: Global

Part of the Technology Updates series, this fact sheet describes PATH's work to assess the value and sustainability of using a simple, affordable spring infusor pump for long-term outpatient administration of antibiotics for the treatment of osteomyelitis in low-resource settings.

Publication date: March 2012

Region: Global

Part of series: Technology Updates

This paper was commissioned for the aids2031 Science and Technology Working Group as part of a series of working papers under the aids2031 initiative. This paper discusses mechanisms that promote innovation in early stage discovery science for HIV and, in particular, those that target existing gaps in research.

Author: International AIDS Vaccine Initiative

Publication date: November 2008

Region: Global

Part of series: aids2031 working papers

This document is the first in a series of periodic policy and practice updates about work undertaken by PATH on the convergence of HIV services and sexual and reproductive health services (SRH) in India.

Author: Sellers T, Saha A, Panda M, Pauchauri A

Publication date: April 2006

Region: Asia

Part of series: HIV-SRH Convergence newsletters

If a highly virulent pandemic strain were to emerge in today’s interconnected world, influenza has the potential to kill millions of people, especially in developing countries with limited to no resources for pandemic planning, preparedness, and outbreak response. PATH's work in developing thermostable influenza vaccines holds promise for extending product shelf life and easing logistics during introduction and rapid deployment to hard-to-reach populations—markedly improving developing-country preparedness and ability to contain the virus at its point of origin. This fact sheet describes our latest research achievements and next steps in product development.

Publication date: September 2013

Region: Global

This report covers a 2009 consultation in Kampala, Uganda, that was convened by the Global Campaign for Microbicides, the Joint UN Programme on HIV/AIDS, and the US Centers for Disease Control and Prevention. It includes recommendations related to key ethical and practical questions on the design and implementation of clinical trials.

Author: McGrory E, Philpott S, Hankins C, Paxton L, Heise L

Publication date: May 2010

Region: Global

This fact sheet describes how the START-UP project is working with private-sector partners to develop two new tests that detect infection with the types of human papillomavirus (HPV) that cause cervical cancer. Designed for use in low-resource settings, these screening tools are an innovative answer to the challenge of early detection of the precursors of cervical cancer.

Publication date: July 2009

Region: Global

Status report on HPV vaccines

Author: Herdman C

Publication date: 2005

Region: Global

Author: Fleming J

Publication date: 2003

Region: Global

This report details malaria research and development funding from 2004 to 2009, including how much funding went to each product area, who provided the funding, and how investments flowed from funders to recipients. The report assesses progress against the Global Malaria Action Plan funding goals to identify what is needed in the next decade.

Publication date: June 2011

Region: Global

Author: Aquino C; D'Agnes L; Castro J; Borromeo M; Schmidt K; Gill K

Publication date: 2003

Region: Global

This document describes project Optimize’s effort to stimulate the development of two new categories of cold chain equipment—solar direct-drive refrigerators and passive-cooled cold boxes—by eliminating key market barriers and providing incentives to manufacturers to meet performance, quality, and safety specifications set by the World Health Organization.

Publication date: August 2013

Region: Global

This series describes the serious risk of freezing vaccines and provides tools to reduce freezing in the cold chain. The materials contain current WHO-recommended freeze-prevention strategies targeted toward all levels of storage and transport of vaccines.

Publication date: 2003

Region: Global

This document helps decision-makers and program planners focus on key “big picture” questions about cervical cancer prioritization and on opportunities and challenges for improved cancer prevention, including vaccination of girls and precancer screening and treatment of adult women.

Publication date: 2011

Region: Global

This document describes the Streamlining Immunization Logistics project, implemented between April 2005 and March 2006 in eight districts of Central Java and Yogyakarta, Indonesia. This project has demonstrated qualitative improvements in the efficiency of sub-national logistic systems supporting the delivery of immunization services.

Author: Lloyd J

Publication date: 2006

Region: Asia

This policy brief describes the study objectives, methodology, and findings from the PATH Convergence Project in India. The brief includes recommendations for developing a national policy in India to converge HIV and reproductive health services for people with HIV and for those most at risk.

Publication date: January 2008

Region: Asia

The Strengthening Communities’ Responses to HIV/AIDS project is a 3-year contract funded by USAID, with two 1-year option periods. PATH is the prime contractor and is joined by four international partners and several local partners. The goal of the project is to strengthen the capacity of civil-society organizations to improve access and quality of HIV care and support services, including counseling and testing and treatment-adherence activities within communities, so that health outcomes for HIV-positive Ethiopians and their dependents are improved.

Publication date: August 2010

Region: Africa

This two-page fact sheet details the procurement systems strengthening work that PATH has done over two decades in over 30 countries.

Publication date: June 2008

Region: Global

PATH is working to promote human milk banking to improve nutrition for infants who are especially vulnerable, such as those in resource-limited settings who are pre-term, low birthweight, severely malnourished, born to HIV-positive mothers, or orphaned. These briefs provide an overview of why human milk banking is important and how it can be integrated within breastfeeding strategies.

Publication date: July 2011

Region: Africa